These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 33526846)

  • 41. Identification of Downstream Genes of the mTOR Pathway that Predict Recurrence and Progression in Non-Muscle Invasive High-Grade Urothelial Carcinoma of the Bladder.
    Jin S; Chang IH; Kim JW; Whang YM; Kim HJ; Hong SA; Lee TJ
    J Korean Med Sci; 2017 Aug; 32(8):1327-1336. PubMed ID: 28665070
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Explore prognostic biomarker of bladder cancer based on competing endogenous network.
    Li F; Guo H; Liu B; Liu N; Xu Z; Wang Y; Zhou H
    Biosci Rep; 2020 Dec; 40(12):. PubMed ID: 33169791
    [TBL] [Abstract][Full Text] [Related]  

  • 43. LncRNA TP73-AS1 Promotes Cell Proliferation and Inhibits Cell Apoptosis in Clear Cell Renal Cell Carcinoma Through Repressing KISS1 Expression and Inactivation of PI3K/Akt/mTOR Signaling Pathway.
    Liu G; Zhao X; Zhou J; Cheng X; Ye Z; Ji Z
    Cell Physiol Biochem; 2018; 48(1):371-384. PubMed ID: 30016766
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A comprehensive immunohistochemical and molecular approach to the PI3K/AKT/mTOR (phosphoinositide 3-kinase/v-akt murine thymoma viral oncogene/mammalian target of rapamycin) pathway in bladder urothelial carcinoma.
    Korkolopoulou P; Levidou G; Trigka EA; Prekete N; Karlou M; Thymara I; Sakellariou S; Fragkou P; Isaiadis D; Pavlopoulos P; Patsouris E; Saetta AA
    BJU Int; 2012 Dec; 110(11 Pt C):E1237-48. PubMed ID: 23107319
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Common and differentially expressed long noncoding RNAs for the characterization of high and low grade bladder cancer.
    Wang M; Xiao X; Zeng F; Xie F; Fan Y; Huang C; Jiang G; Wang L
    Gene; 2016 Oct; 592(1):78-85. PubMed ID: 27451077
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Long non-coding RNAs as new players in bladder cancer: Lessons from pre-clinical and clinical studies.
    Mirzaei S; Paskeh MDA; Hashemi F; Zabolian A; Hashemi M; Entezari M; Tabari T; Ashrafizadeh M; Raee P; Aghamiri S; Aref AR; Leong HC; Kumar AP; Samarghandian S; Zarrabi A; Hushmandi K
    Life Sci; 2022 Jan; 288():119948. PubMed ID: 34520771
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Expression signatures of exosomal long non-coding RNAs in urine serve as novel non-invasive biomarkers for diagnosis and recurrence prediction of bladder cancer.
    Zhan Y; Du L; Wang L; Jiang X; Zhang S; Li J; Yan K; Duan W; Zhao Y; Wang L; Wang Y; Wang C
    Mol Cancer; 2018 Sep; 17(1):142. PubMed ID: 30268126
    [TBL] [Abstract][Full Text] [Related]  

  • 48. LINC00312 inhibits the migration and invasion of bladder cancer cells by targeting miR-197-3p.
    Wang YY; Wu ZY; Wang GC; Liu K; Niu XB; Gu S; Meng JS
    Tumour Biol; 2016 Nov; 37(11):14553-14563. PubMed ID: 27631965
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Long non-coding RNA urothelial cancer-associated 1 promotes bladder cancer cell migration and invasion by way of the hsa-miR-145-ZEB1/2-FSCN1 pathway.
    Xue M; Pang H; Li X; Li H; Pan J; Chen W
    Cancer Sci; 2016 Jan; 107(1):18-27. PubMed ID: 26544536
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Regulator of cullins-1 expression knockdown suppresses the malignant progression of muscle-invasive transitional cell carcinoma by regulating mTOR/DEPTOR pathway.
    Wang W; Chen H; Liu Z; Qu P; Lan J; Chen H; Zou L; Qiu J
    Br J Cancer; 2016 Feb; 114(3):305-13. PubMed ID: 26742010
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Exosomal LINC00355 derived from cancer-associated fibroblasts promotes bladder cancer cell proliferation and invasion by regulating miR-15a-5p/HMGA2 axis.
    Zhang Y; Luo G; You S; Zhang L; Liang C; Chen X
    Acta Biochim Biophys Sin (Shanghai); 2021 May; 53(6):673-682. PubMed ID: 33882126
    [TBL] [Abstract][Full Text] [Related]  

  • 52. LncRNA TP73-AS1 predicts the prognosis of bladder cancer patients and functions as a suppressor for bladder cancer by EMT pathway.
    Tuo Z; Zhang J; Xue W
    Biochem Biophys Res Commun; 2018 May; 499(4):875-881. PubMed ID: 29625110
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Long non-coding RNA TTN-AS1 facilitates tumorigenesis of papillary thyroid cancer through modulating the miR-153-3p/ZNRF2 axis.
    Cui Z; Luo Z; Lin Z; Shi L; Hong Y; Yan C
    J Gene Med; 2019 May; 21(5):e3083. PubMed ID: 30811764
    [TBL] [Abstract][Full Text] [Related]  

  • 54. LncRNA SNHG6 inhibits cell proliferation and metastasis by targeting ETS1 via the PI3K/AKT/mTOR pathway in colorectal cancer.
    Meng S; Jian Z; Yan X; Li J; Zhang R
    Mol Med Rep; 2019 Sep; 20(3):2541-2548. PubMed ID: 31322251
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Long noncoding RNAs in the mTOR signaling network: biomarkers and therapeutic targets.
    Huang T; Wang M; Huang B; Chang A; Liu F; Zhang Y; Jiang B
    Apoptosis; 2018 Jun; 23(5-6):255-264. PubMed ID: 29556906
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Long non-coding RNA CASC9 promotes tumor growth and metastasis via modulating FZD6/Wnt/β-catenin signaling pathway in bladder cancer.
    Zhan Y; Zhang L; Yu S; Wen J; Liu Y; Zhang X
    J Exp Clin Cancer Res; 2020 Jul; 39(1):136. PubMed ID: 32677984
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Increased expression of SPRY4-IT1 predicts poor prognosis and promotes tumor growth and metastasis in bladder cancer.
    Zhao XL; Zhao ZH; Xu WC; Hou JQ; Du XY
    Int J Clin Exp Pathol; 2015; 8(2):1954-60. PubMed ID: 25973088
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Circular RNA circPICALM sponges miR-1265 to inhibit bladder cancer metastasis and influence FAK phosphorylation.
    Yan D; Dong W; He Q; Yang M; Huang L; Kong J; Qin H; Lin T; Huang J
    EBioMedicine; 2019 Oct; 48():316-331. PubMed ID: 31648990
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Lnc-MUC20-9 binds to ROCK1 and functions as a tumor suppressor in bladder cancer.
    Dai R; Zhou Y; Chen Z; Zou Z; Pan Z; Liu P; Gao X
    J Cell Biochem; 2020 Oct; 121(10):4214-4225. PubMed ID: 31898364
    [TBL] [Abstract][Full Text] [Related]  

  • 60. DANCR Promotes Metastasis and Proliferation in Bladder Cancer Cells by Enhancing IL-11-STAT3 Signaling and CCND1 Expression.
    Chen Z; Chen X; Xie R; Huang M; Dong W; Han J; Zhang J; Zhou Q; Li H; Huang J; Lin T
    Mol Ther; 2019 Feb; 27(2):326-341. PubMed ID: 30660488
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.